Recently, Walgreens, the largest chain drug store in the United States, announced that it has stopped cooperation with Theranos. The company said that Allanos' "all 40 health centers" at the Walgreens pharmacy in Arizona will be closed immediately. Brad Fluegel Walgreens vice president, said in a statement: "In view of the large number of companies Theranos test results void, while Medicare and Medicaid centers have also been rejected Theranos company's corrective action plan, we have to seriously consider after the partnership with Theranos It is believed that the termination of the partnership will be in the best interests of our customers." Following an article in the Wall Street Journal last October that Theranos seriously exaggerated its technical capabilities, Walgreens terminated plans to open more Theranos Health Center. A spokesperson for Theranos said: "We are very disappointed that Walgreens chose to terminate our partnership. We are still committed to providing patients with health information and hope to pass our own retail stores in Arizona and California. Continue to provide services to customers. †Since last October, the Wall Street Journal has been bombarding Theranos, and most of the company's blood tests have not used Edsion equipment. After only one of the 240 tests used its own technology, Theranos began to walk down the altar. And on the verge of ruin. Since January of this year, the CMS (US Medicare and Medicaid Service Center) has accelerated the rhythm of the Theranos building. CMS said that Theranos's operation process and test results have a lot of defects. In March, CMS sent more than 40 pages of letters to Theranos, proposing six penalties, including the suspension of the California lab license, and the issuance of a 121-page survey that pointed out several major problems with Theranos: basic testing procedures, The staff lacks training and informs the patient of inaccurate test results. Although Theranos made some remedies for these problems, the results still did not convince the public. Not only is the technology questioned, the financial situation of Theranos is not optimistic. According to regulatory documents in February, the company has about $750 million in funding, but Theranos may not use the money effectively. According to The Wall Street Journal, when Theranos outsourced blood testing services to the University of California, the cost of completing a test by Theranos at the University of California was more than $300, while Theranos only charged $7.19 for the patient, and the difference was filled by Theranos himself. Many investors and analysts have determined that the company has economic problems. The house leaks all night, and Theranos's cooperative partners began to clear their relationship with him. Prior to Walgreens, Theranos set up blood collection sites at pharmacies and grocery stores across the country to collect blood samples from patients for blood testing, but now these partners are withdrawing this collaboration. Many chain pharmacies have suspended their cooperation with Theranos and no longer set up blood collection points. The Safeway supermarket chain also disbanded the partnership with Theranos after investing $350 million to build 800 grocery collection points. Household Clearing Nitrile Gloves Household Clearing Nitrile Gloves,Safety Nitrile Gloves,Oilproof Nitrile Gloves,Household Gloves Prevent Allergic Puyang Linshi Medical Supplies Co., Ltd. , https://www.linshihealths.com